首页> 外国专利> Analysis summary of calcium phosphate and its components and uses

Analysis summary of calcium phosphate and its components and uses

机译:磷酸钙及其成分和用途的分析总结

摘要

Permeable membrane phosphate analogues, pharmaceutical ingredients containing permeable membrane phosphate analogues, and methods for treating diseases such as ischemic ischemia and heart failure; Neurodegenerative disorders and genetic disorders affect the pentachloroenzyme system, including the extensive management of calcium phosphate analogues and their pharmaceutical components. Treatment of genetic diseases affecting the quininase system, for example,A disorder of a cretin transmitter or a disorder of cretin synthesis, including the management of phosphine analogues and their pharmaceutical components. 1. Claim 1: a formula compound (1),Formula (1a),Formula (2)Formula (3) or one of its salts; pharmaceutically acceptable solution, ceramic photometer or stereoisomer: wherein, formula (1) compounds are as follows: res-ch8323o-cd8323a;R1 is hydrogen or 2-C (O) OR-C (O) R-C (O) OCH (CH) OC (O) (CH) CH (R) NH-C (O) OCH (CH₃) OC (O) (CH₂) ₘCH (R¹¹) N (H) C (O) (CH₂) ₘCH (R¹¹) NH₂,-CH (CH₃) O-C (O) (CH₂) ₘCH (R¹¹) N (H) C (O) (CH₂) ₘCH (R¹²) N (H) C (O) (CH₂) ₘCH (R¹³) NH₂,-COC (CH) CH R-Coch8322; - ch8322; - r8313 or compounds selected from the formula group (4);N is an integer from 1 to 2; m is an integer from 0 to 1; each R 1,R¹² and R¹³ is, independently, an amino acid side chain; R¹⁹ is hydrogen, -C₁₋₈-alkyl or -C₁₋₆-alkyl,a. Replaced by a major hydroxyl, anthrax, or ammonia group; each R2 is an independent hydrogen, hydrocarbon c833318321; andC₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl C₄₋₂₀-substituted cycloalkylalkyl, C₄₋₂₀-heterocycloalkylalkyl,e. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl or C₆₋₂₀-substituted heteroarylalkyl; each R³ and R⁴ is independently hydrogen, C₁₋₁₂-alkyl or C₁₋₁₂-substituted alkyl; R²³ is hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₅₋₁₂-cycloalkyl,C₅₋₁₂-substituted cycloalkyl, C₅₋₁₂-aryl and C₅₋₁₂-substituted aryl, -C (O) -OR²² or -C (O) -R²²;R²² is C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl or C₆₋₂₀-substituted heteroarylalkyl; R⁴⁸ is hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₅₋₁₂-aryl,arilo C sustituido cicloalquilo C o cicloalquilo C sustituido Y es -NHCH (R) C (O) OR-83099,Or by a set of formulas (5);X is O or S; each R⁵ and R⁶ is independently hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl or C₆₋₂₀-substituted heteroarylalkyl; R⁹ is hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl,e. Heterosexuality;Instead, - C (o) r83099,-C (O) ORC (O) (NR R)-C (R R) -C (O) OR-C (R R) - (O) C (O) -RC (R R) - (O) C (O) -OROr by a set of formulas (6);R²⁵ is C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl or C₆₋₂₀-substituted heteroarylalkyl; and R²⁰ is hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₅₋₁₂-aryl,C₅₋₁₂ substituted aryl, C₃₋₁₂ cycloalkyl,a. A compound (7) substituted by or selected from the formula group;a. The compounds of formula (1a) are listed as follows: and es-nhc (R1) C (o) ORRO 83044;-83099,Or by a set of formulas (5);X is O or S; each R⁵ and R⁶ is independently hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl or C₆₋₂₀-substituted heteroarylalkyl; R⁹ is hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl,a. Unorthodox c832626;C (O) ORC (O) (NR R)-C (R R) -C (O) OR-C (R R) - (O) C (O) RC (R R) - (O) C (O) -OROr by a set of formulas (6);R²⁵ is C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl or C₆₋₂₀-substituted heteroarylalkyl; R²⁰ is hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₅₋₁₂-aryl,C₅₋₁₂ substituted aryl, C₃₋₁₂ cycloalkyl,C₃₋₁₂-substituted cycloalkyl, or a compound from the group of formulas (7);R, R1,R3,R830808,R83099,R8310,R1,R²² and R²³ are as defined herein; wherein the compound of formula (2) is as detailed below, where Y and Z are each, independently, NHCH (R¹¹) C (O) OR²⁰,-83099,Or compounds selected from the formula group (5);X is O or S; each R⁵ and R⁶ is independently hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl or C₆₋₂₀-substituted heteroarylalkyl; R⁹ is hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,arilalquilo C sustituido heteroarilalquilo C heteroarilalquilo CInstead, - C (o) r83099,C (O) ORC (O) (NR R)-C (R R) -C (O) OR-C (R R) - (O) C (O) RC (R R) - (O) C (O) -OROr by a set of formulas (6);R²⁵ is C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,C₆₋₂₀-substituted arylalkyl, C₆₋₂₀-heteroarylalkyl or C₆₋₂₀-substituted heteroarylalkyl; R²⁰ is hydrogen, C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₅₋₁₂-aryl,C₅₋₁₂ substituted aryl, C₃₋₁₂ cycloalkyl,C₃₋₁₂-substituted cycloalkyl, or a compound from the group of formulas (7);R, R1,R3,R830808,R83099,R8310,R1,2. R2 and R2 3 are defined in this document; in this document, the compounds of formula (3) are as follows, wherein 1 and 1 are independent; NHC (R1) C (o) or * 83044;-83099,Or by a set of formulas (5);1. Y1 and Z1 cannot be a set of formulas (8) at the same time;R²⁵ is C₁₋₁₂ alkyl,C₁₋₁₂-substituted alkyl, C₁₋₁₂-heteroalkyl,C₁₋₁₂-substituted heteroalkyl, C₃₋₁₂-cycloalkyl,C₃₋₁₂-substituted cycloalkyl, C₄₋₂₀-cycloalkylalkyl,cicloalquilalquilo C sustituido heterocicloalquilalquilo Ce. Straight ring tequila;C₅₋₁₂ substituted aryl, C₅₋₁₂ heteroaryl,C₅₋₁₂ substituted heteroaryl, C₆₋₂₀ arylalkyl,arilalquilo C sustituido heteroarilalquilo C o heteroarilalquilo C sustituido y R RR3,R830808,R83099,R8310,R1,2.2.1.2 and 2.3 are defined in this article.
机译:渗透膜磷酸盐类似物,含有渗透膜磷酸盐类似物的药物成分以及治疗诸如缺血性缺血和心力衰竭等疾病的方法;神经退行性疾病和遗传疾病会影响五氯酶系统,包括广泛管理磷酸钙类似物及其药物成分。影响奎宁酶系统的遗传疾病的治疗,例如,克汀素递质的疾病或克汀素合成的疾病,包括膦类似物及其药物成分的管理。 1.权利要求1的式化合物(1),式(1a),式(2),式(3)或其盐之一;药学上可接受的溶液,陶瓷光度计或立体异构体:其中,式(1)化合物如下:res-ch8323o-cd8323a; R1为氢或2-C(O)OR-C(O)RC(O)OCH(CH) OC(O)(CH)CH(R)NH-C(O)OCH(CH 3)OC(O)(CH 2)ₘCH(R 11)N(H)C(O)(CH 2)ₘCH(R¹)NH 2 CH(CH 3)OC(O)(CH 2)ₘCH(R 1)N(H)C(O)(CH 2)ₘCH(R 12)N(H)C(O)(CH 2)ₘCH(R 13)NH 2- CH)CH R-Coch8322; -ch8322; -r8313或选自式组(4)的化合物; N为1-2的整数; m是0至1的整数; R 1,R 12和R 13各自独立地是氨基酸侧链; R 10为氢,-C 1-烷基或-C 1-烷基,a。被主要的羟基,炭疽或氨基取代;每个R 2是独立的氢,烃c833318321; C 12-取代的烷基,C 12-22-杂烷基,C 12-取代的杂烷基,C 12-12-环烷基,C 12-取代的环烷基,C 12-12-环烷基烷基,C 12-12-取代的环烷基烷基,C 12-12-杂环烷基。 ,e。直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12 -22芳基烷基,C 12 -22取代的芳基烷基,C 12 -C 16杂芳基烷基或C 12 -22取代的杂芳基烷基; R 3和R 6各自独立地是氢,C 1-2-烷基或C 1-2-取代的烷基; R 23是氢,C 12烷基,C 12取代的烷基,C 12环烷基,C 12取代的环烷基,C 12芳基和C 12取代的芳基,-C(O)-OR 22或-C(O)-R 22; R 22是C 12烷基,C 12取代的烷基,C 12-22杂烷基,C 12取代的杂烷基,C 12-22环烷基,C 12取代的环烷基,C 16 20-环烷基烷基,环庚基C sustituido杂环喹基Ce。直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12 -22芳基烷基,C 12 -22取代的芳基烷基,C 12 -C 16杂芳基烷基或C 12 -22取代的杂芳基烷基; R 7是氢,C 12-22烷基,C 12-22取代的烷基,C 12-22芳基,芳基C sustituido cicloalquilo C o cicloalquilo C sustituido Y es -NHCH(R)C(O)OR-830​​99,或式(5); X为O或S; R 1和R 6各自独立地是氢,C 1-2烷基,C 1-2取代的烷基,C 1-2杂烷基,C 1-2取代的杂烷基,C 1-2环烷基,C 1-2取代的环烷基,C 1-2。环烷基烷基,cicloalquilalquilo Ce。直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12 -22芳基烷基,C 12 -22取代的芳基烷基,C 12 -C 16杂芳基烷基或C 12 -22取代的杂芳基烷基; R 7是氢,C 12-22烷基,C 12-22取代的烷基,C 12-22杂烷基,C 12-22取代的杂烷基,C 12-22环烷基,C 12取代的环烷基,C 12-12环烷基烷基,环氯代喹啉基C sustituido heterocicloalquilalquilo Ce。直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12 -22芳基烷基,C 12 -22取代的芳基烷基,C 12-22杂芳基烷基,e。异性;相反,-C(o)r83099,-C(O)ORC(O)(NR R)-C(RR)-C(O)OR-C(RR)-(O)C(O)-RC (RR)-(O)C(O)-OR或用一组式(6)表示; R 20为C 12烷基,C 12-22取代的烷基,C 12-22杂烷基,C 12-22取代的杂烷基,C 8十二-环烷基,C 1-2取代的环烷基,C 1-2-环烷基烷基,环己基喹啉基C sustituido异环喹啉基Ce。直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12 -22芳基烷基,C 12 -22取代的芳基烷基,C 12 -C 16杂芳基烷基或C 12 -22取代的杂芳基烷基; R 2是氢,C 12烷基,C 12-22取代的烷基,C 12-22芳基,C 12取代的芳基,C 12环烷基,a。被式组取代或选自式组的化合物(7); a。式(1a)的化合物如下:和es-nhc(R1)C(o)ORRO 83044; -83099,或由一组式(5)表示; X为O或S; R 1和R 6各自独立地是氢,C 1-2烷基,C 1-2取代的烷基,C 1-2杂烷基,C 1-2取代的杂烷基,C 1-2环烷基,C 1-2取代的环烷基,C 1-2。环烷基烷基,cicloalquilalquilo Ce。直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12 -22芳基烷基,C 12 -22取代的芳基烷基,C 12 -C 16杂芳基烷基或C 12 -22取代的杂芳基烷基; R 7是氢,C 12-22烷基,C 12-22取代的烷基,C 12-22杂烷基,C 12取代的杂烷基,C 12-22环烷基,C 12取代的环烷基,C 12-22环烷基烷基,环烷基芳基C sustituido杂环烷基芳基Ce。直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12-22芳基烷基,C 12-取代的芳基烷基,C 12-22杂芳基烷基,a。非正统c832626; C(O)ORC(O)(NR R)-C(RR)-C(O)OR-C(RR)-(O)C(O)RC(RR)-(O)C(O )-或通过一组式(6)表示; R 20为C 12烷基,C 12取代的烷基,C 12-22杂烷基,C 12取代的杂烷基,C 12环烷基,C 12取代环烷基,C 12 -C 8-环烷基烷基,环庚基C sustituido杂环庚基Ce。直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12 -22芳基烷基,C 12 -22取代的芳基烷基,C 12 -C 16杂芳基烷基或C 12 -22取代的杂芳基烷基; R 20是氢,C 12烷基,C 12取代的烷基,C 12-22芳基,C 12取代的芳基,C 12环烷基,C 12取代的环烷基或式(7)组的化合物。 R,R 1,R 3,R 830808,R 83099,R 8310,R 1,R 2 2和R 2 3如本文所定义;其中式(2)的化合物如下所述,其中Y和Z分别独立地为NHCH(R 11)C(O)OR 20 -83099,或选自式组(5)的化合物; X为O或S; R 1和R 6各自独立地是氢,C 1-2烷基,C 1-2取代的烷基,C 1-2杂烷基,C 1-2取代的杂烷基,C 1-2环烷基,C 1-2取代的环烷基,C 1-2。环烷基烷基,cicloalquilalquilo Ce。直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12 -22芳基烷基,C 12 -22取代的芳基烷基,C 12 -C 16杂芳基烷基或C 12 -22取代的杂芳基烷基; R 7是氢,C 12-22烷基,C 12-22取代的烷基,C 12-22杂烷基,C 12-22取代的杂烷基,C 12-22环烷基,C 12取代的环烷基,C 12-12环烷基烷基,环氯代喹啉基C sustituido heterocicloalquilalquilo Ce。直环龙舌兰酒; C 12取代的芳基,C 1-2杂芳基,C 1-2取代的杂芳基,C 1-2芳基烷基,芳基芳基C sustituido杂芳基芳基C杂芳基基C代替,-C(o)r83099,C(O)ORC(O)( NR R)-C(RR)-C(O)OR-C(RR)-(O)C(O)RC(RR)-(O)C(O)-OR或通过一组公式(6); R 20是C 12烷基,C 12取代的烷基,C 12-22杂烷基,C 12取代的杂烷基,C 12-22环烷基,C 12取代的环烷基,C 12-12环烷基烷基,环氯代喹啉基C sustituido杂环氯代喹啉基铈直环龙舌兰酒; C 12-取代的芳基,C 12-杂芳基,C 12取代的杂芳基,C 12 -22芳基烷基,C 12 -22取代的芳基烷基,C 12 -C 16杂芳基烷基或C 12 -22取代的杂芳基烷基; R 20是氢,C 12烷基,C 12取代的烷基,C 12-22芳基,C 12取代的芳基,C 12环烷基,C 12取代的环烷基或式(7)组的化合物。 ); R,R1,R3,R830808,R83099,R8310,R1,2。 R2和R2 3在本文档中定义;在该文件中,式(3)化合物如下,其中1和1是独立的; NHC(R1)C(o)或* 83044; -83099,或通过一组公式(5); 1。 Y 1和Z 1不能同时是一组式(8); R 20是C 12烷基,C 12-22取代的烷基,C 12-22杂烷基,C 12 2取代的杂烷基,C 12-22环烷基, C 12-取代的环烷基,C 12-12-环烷基烷基,环庚基C sustituido杂环庚基Ce。直环龙舌兰酒; C 1-2取代的芳基,C 1-2杂芳基,C 1-2取代的杂芳基,C 1-2芳基烷基,芳基芳基C sustituido杂芳基芳基C o杂芳基芳基C sustituido y R RR3,R830808,R83099,R8310,R1,2.2.1.2和2.3在本文中定义。

著录项

  • 公开/公告号AR104144A1

    专利类型

  • 公开/公告日2017-06-28

    原文格式PDF

  • 申请/专利权人 FARMINGTON PHARMA DEVELOPMENT;

    申请/专利号AR2016P100855

  • 发明设计人 WILLIAM F. BRUBAKER;

    申请日2016-03-30

  • 分类号C07F9/645;A61K31/66;A61P25;

  • 国家 AR

  • 入库时间 2022-08-21 13:41:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号